The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Sensus Healthcare, Inc. (SRTS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Sensus Healthcare, Inc. is a member of our Medical group, which includes 1046 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA, IR Joe Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Yi Chen - H.C. Wainwright & Co. Anthony Vendetti - Maxim Group Operator Good day, and welcome to the Sensus Healthcare First Quarter 2024 Financial results Conference Call. [Operator Instructions] Please note, this event is being recorded. I wo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | ...

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 9, 2024) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2024. Exhibit 99.1 Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold Highlights from the first qua ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Commission File Number: 001-37714 (State or other jurisdiction of incorporation or organization) 851 Broken Sound Pkwy., NW #215, Boca Raton, Sen ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Conference Call February 8, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA, IR Joe Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Yi Chen - H.C. Wainwright Anthony Vendetti - Maxim Group Ben Haynor - Alliance Global Partners Operator Good day and welcome to the Sensus Healthcare Fourth Quarter and Full Year 2023 Financial Results Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Kim Sutton Golodetz - LHA, IR Joe Sardano - Chairman & CEO Michael Sardano - President & General Counsel Javier Rampolla - CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Alex Nowak - Craig-Hallum Capital Group Ben Haynor - Alliance Global Partners Operator Good afternoon and welcome to the Sensus Healthcare Third Quarter 2023 Financial Results Conference Call. All ...

OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 1934 For the transition period from______________to _____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | | | (State or other juris ...

Sensus Healthcare, Inc (NASDAQ:SRTS) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Kim Golodetz - IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Scott Henry - ROTH Capital Anthony Vendetti - Maxim Group Ben Haynor - Alliance Global Partners Operator Welcome to the Sensus Healthcare Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being ...